TY - JOUR
T1 - Sleep medicine pharmacotherapeutics overview
T2 - Today, tomorrow, and the future (Part 2: Hypersomnia, parasomnia, and movement disorders)
AU - Gulyani, Seema
AU - Salas, Rachel E.
AU - Gamaldo, Charlene E.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2013/1
Y1 - 2013/1
N2 - Over the past 10 years, significant strides have been made in therapeutics for sleep disorders. In this second installment of a two-part review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the current over-the-counter and pharmacotherapeutics for hypersomnia, parasomnias, and movement disorders of sleep.
AB - Over the past 10 years, significant strides have been made in therapeutics for sleep disorders. In this second installment of a two-part review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the current over-the-counter and pharmacotherapeutics for hypersomnia, parasomnias, and movement disorders of sleep.
UR - http://www.scopus.com/inward/record.url?scp=84871964370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871964370&partnerID=8YFLogxK
U2 - 10.1378/chest.12-0561
DO - 10.1378/chest.12-0561
M3 - Article
C2 - 23276849
AN - SCOPUS:84871964370
VL - 143
SP - 242
EP - 251
JO - Diseases of the chest
JF - Diseases of the chest
SN - 0012-3692
IS - 1
ER -